Guest guest Posted January 31, 2007 Report Share Posted January 31, 2007 He Everyone, Quite some time ago I posted an abstract that showed how Gleevec inhibited c-fms but at the time, this implication wasn't well understood. In the past we've seen concerns that Gleevec may negatively impact bone development especially in those who tend to be low on phosphorus but this article seems to indicate that Gleevec can be useful to treat various bone diseases such as osteoporosis, metastatic bone disease, and multiple myeloma because of the fact that it inhibits this enzyme called c-fms. I hope will be able to " translate " this article for us so that we can understand it better. http://www.bloodjournal.org/cgi/content/abstract/107/11/4334? maxtoshow= & HITS=10 & hits=10 & RESULTFORMAT= & fulltext=imatinib & searchid=1 & FIRSTINDEX=0 & sortspec=relevance & resourcetype=HWCIT Tracey PS- In case the link doesn't work, the title of the article is " Imatinib as a potential antiresorptive therapy for bone disease " and I found it in Blood, 1 June 2006, Vol. 107, No. 11, pp. 4334-4337. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.